InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Kropotova Alexandra, Directeur Médical. Officer active across 1 company, notably SAB Biotherapeutics, Inc.. Cumulatively, 5 reports have been recorded. Activity tracked since 6 June 2022. The latest transaction was filed on 6 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Alexandra Kropotova is the Chief Medical Officer at SAB Biotherapeutics, Inc. She is responsible for leading the company's medical initiatives and research strategy. Alexandra brings clinical and scientific expertise to support the development of innovative products.